Beth Israel Lahey Health and Joslin Diabetes Center sign letter of intent
Beth Israel Lahey HealthBeth Israel Lahey Health and Joslin Diabetes Center have signed a non-binding Letter of Intent to explore opportunities for Joslin to join BILH.
Beth Israel Lahey Health and Joslin Diabetes Center have signed a non-binding Letter of Intent to explore opportunities for Joslin to join BILH.
Type 1 diabetes (T1D) is the third most common pediatric chronic disease in the United States, and the risk of the disease has risen sharply in non-Hispanic Black (NHB) children in the last 20 years, data show. Ironically, the significant advances in T1D therapeutics over recent years, especially new technologies, may have exacerbated racial disparities in diabetes treatment and outcomes
A collaboration to accelerate research to cure type 1 diabetes and improve lives.
In a mouse study aimed at modeling human exposure to the toxic metal cadmium, researchers found that female offspring of mice exposed to cadmium during pregnancy became obese in adulthood, developed fatty livers and could not process glucose normally. Male offspring were not affected in the same way.
A new UC Riverside study shows flame retardants found in nearly every American home cause mice to give birth to offspring that become diabetic.
DALLAS – Nov. 9, 2020 – Reducing the level of body fat and waist size are linked to a lower risk of heart failure in patients with type 2 diabetes, a study led by UT Southwestern researchers indicates. The findings, reported today in Circulation, suggest that all weight loss isn’t equal when it comes to mitigating the risk of heart disease.
With multiple studies showing that COVID deaths and complications increase step-by-step with increasing blood sugar levels, a groundbreaking Newswise Webinar on Thursday November 12th from 2 to 3 pm ET will examine national, clinical and community strategies to immediately improve COVID outcomes through comprehensive nutrition information and action.
In the spring of 2020, just as it became clear that New York’s long-ignored diabetes epidemic was accelerating rampant COVID sickness and death, the federal government and the New York State Department of Health defunded our successful diabetes self-management program in the South Bronx.
Researchers from the University of Sherbrooke, Canada, tested the effects of a 12-week HIIT regimen on the physiological parameters—specifically gene expression in monocytes—of women with type 2 diabetes who developed cardiovascular disease. The findings show HIIT reduced the expression of 56 genes known to be associated with inflammation. This suggests HIIT could mitigate inflammation, resulting in favorable physiological adaptions in women with type 2 diabetes.
A new study from the University of Eastern Finland shows that individualised and family-based physical activity and dietary counselling considerably slows down the development of insulin resistance, which is a precursor of type 2 diabetes, in 6-9-year-old children. Published in Diabetologia, the study focused on predominantly normal-weight children.
A recent study conducted by physicians across the country shows promise for a new treatment option for patients suffering chronic pain from diabetic neuropathy. The treatment entails spinal cord stimulator implantation, a technique commonly associated with chronic back and leg pain treatment.
More than 34 million people in the U.S, or 10.5% of the population, have diabetes, according to the Centers for Disease Control and Prevention. And as many as 7 million more Americans have the disease and don’t know it. Diabetes is the seventh-leading cause of death in the country..
GLP-1 receptor agonists and SGLT2 inhibitors reduce high blood sugar and adverse events related to heart and kidney disease, but cardiologists rarely prescribe these drugs. A leading group of diabetes doctors and cardiologists are trying to change that.
Patients whose Type 2 diabetes is not controlled with metformin can benefit long-term from a two-drug combination treatment that also reduces weight.
The Association of Diabetes Care & Education Specialists (ADCES) today announced the results of a national survey that uncovered people living with diabetes are challenged by tracking information related to their condition over time.
La retinopatía diabética es la causa más común de ceguera en los adultos de edad laboral; sin embargo, la mayoría de los estadounidenses de más de 40 años no conocen sus síntomas ni los factores de riesgo para esta afección común que amenaza la vista, según una encuesta encomendada por la Sociedad Estadounidense de Especialistas en Retina (American Society of Retina Specialists, ASRS).
Diabetic retinopathy is the leading cause of blindness among working-age adults, yet most Americans over 40 don’t know its symptoms or the risk factors for this common sight-threatening condition, according to a survey commissioned by the American Society of Retina Specialists (ASRS).
All adults with endocrine disorders should be tested for high cholesterol and triglycerides to evaluate their risk of heart attack or stroke, according to a Clinical Practice Guideline issued today by the Endocrine Society.
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effect.
The Association of Diabetes Care & Education Specialists Foundation and the Certification Board for Diabetes Care and Education are proud to award Julia Blanchette Ph.D., RN, CDCES, a fellowship in integrated diabetes management.
What about the kidneys make them a hotspot for COVID-19’s cytokine storm? A research team says it’s the presence of a protein found on specialized renal transport cells.
Patients with diabetic kidney disease can potentially be treated with a new investigational medication that may slow the progress of their illness without harmful side effects to their hearts, according to the results of a global clinical trial announced Friday.
Transplanting cadaver pancreatic islets is a promising therapy for Type 1 diabetes, but a reactivated autoimmunity means low graft viability after five years. Research now shows that a protective coating of two biopolymers can delay allograft and autoimmune-mediated rejection in mouse models of T1D.
New research in mice suggests that a high-fat diet early in life may impair male fertility in adulthood. The first-of-its-kind study is published ahead of print in the American Journal of Physiology-Endocrinology and Metabolism.
The COVID-19 pandemic has jumpstarted innovation in health care delivery and allowed for real-world testing of diabetes care models in unprecedented ways, according to a manuscript published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Researchers at the University of Chicago Medicine are launching a four-year research trial to test the effects of two evidenced-based interventions for personalized diabetes care for older adults, thanks to a new $5 million grant provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health.
It's long been thought that having "autoreactive" T cells in the pancreas was a sure sign of type 1 diabetes. Yet a new study led by scientists at La Jolla Institute for Immunology (LJI) shows that even healthy people have these cells lurking in the pancreas—in surprisingly high numbers.
The Cardiometabolic Center Alliance (CMCA), founded by Saint Luke’s Mid America Heart Institute is pleased to announce the addition of University Hospitals Cleveland Medical Center as Key Strategic Partner and Charter Member. As a coalition that seeks to establish Cardiometabolic Centers of Excellence nationwide aimed at transforming the treatment of type 2 diabetes (T2D) and related cardiovascular (CV) and renal comorbidities, the CMCA considers University Hospitals (UH) a large integrated health system based in Cleveland, Ohio a key member of the Alliance.
Data from COMBINE (OCT-FFR) found that the use of FFR combined with OCT imaging can help improve the accuracy of high-risk lesion identification in patients with diabetes. Findings were reported today at TCT Connect, the 32nd annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine.
While older age is widely recognized as a risk factor for increased morbidity and mortality due to COVID-19, younger patients have received less attention as a population vulnerable to adverse clinical outcomes.
Media invited to live Q&A on Oct 7th, 2pm EDT
Insulin pumps are widely used in the management of type 1 diabetes (T1D) and reviews have shown insulin pump therapy to be associated with improved glycemic control, fewer severe hypoglycemia events, and improved quality of life. Yet, non-Hispanic white children (NHW) are more than twice as likely as non-Hispanic Black children (NHB) to use this technology.
A premier medical education opportunity for nurse practitioners and physician assistants.
Innovative device ensures doctors obtain adequate fluid samples from the eye, helping with diagnosis and individualized treatment plans for patients.
New findings about body fat help explain the differing health risks men and women face – and set the stage for better, more targeted treatments.
Today, U.S. Senators Tim Scott (R-SC), Mark Warner (D-VA), Kevin Cramer (R-ND), Kyrsten Sinema (D-AZ), Tom Cotton (R-AR), and Tina Smith (D-MN) introduced the PREVENT DIABETES Act. This legislation would increase access to the Medicare Diabetes Prevention Program (MDPP) Expanded Model by allowing CDC-recognized virtual suppliers to participate in the program.
The University of New Hampshire will receive $1.8 million from the National Institutes of Health (NIH) that will further molecular research to better understand drug interactions at the cellular level and help lead to the development of new targeted drugs to treat wide-spread metabolic, growth, neurological and visual disorders including diabetes and cancer.
Patients taking drugs called NRTIs to treat HIV and hepatitis B had a 33% lower risk of developing diabetes.
A Cleveland Clinic study shows that 5 to 10 percent of surgically induced weight loss is associated with improved life expectancy and cardiovascular health. In comparison, about 20 percent weight loss is necessary to observe similar benefits with a non-surgical treatment. The findings also show that metabolic surgery may contribute health benefits that are independent of weight loss. The study is published in the October issue of Annals of Surgery.
A study led by UC Davis Health researchers uncovered that even one severe episode of diabetic ketoacidosis (DKA) in children newly diagnosed with type 1 diabetes is linked to cognitive problems; and among children with a previous diagnosis, repeated DKA exposure predicted lower cognitive performance after accounting for glycemic control.
Researchers found that Black young adults who grew up amid economic hardship and exposure to racial discrimination experienced physical deterioration that persisted through adolescence and well into adulthood—even though on the surface, they were successful.
Early to bed, early to rise…while the old saying promises health, wealth and wisdom, new research confirms part of the adage holds true, as a world first study shows that people who go to bed early are more likely to be in better health and more physically active compared to night owls.
The Endocrine Society will switch its annual meeting, ENDO 2021, to a fully virtual format, the Society announced today.
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.
DALLAS – Sept. 15, 2020 – Conditions related to obesity, including inflammation and leaky gut, leave the lungs of obese patients more susceptible to COVID-19 and may explain why they are more likely to die from the disease, UTSW scientists say in a new article published online in eLife. They suggest that drugs used to lower inflammation in the lungs could prove beneficial to obese patients with the disease.
Published in the journal Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]), the study shows that it is the absence of quality connections with people and not the lack of contact that predicts the onset of type 2 diabetes, suggesting that helping people form and experience positive relationships could be a useful tool in prevention strategies for type 2 diabetes.
The combined effects of the body's microbiota working together with COVID-19 in the lungs could explain the severity of the disease in people with obesity and diabetes, according to a new article published today in eLife.
COVID-19 and interlinkages to endocrine and metabolic diseases was an important programme topic at the 2020 European Congress of Endocrinology.